Executive Sangjin Kim increases stake to 0.08% via open market purchase of 3,000 shares at KRW 17,869
-
Non-registered executive (President) Sangjin Kim purchased 3,000 common shares via open market on 2026.05.15 at an average price of KRW 17,869.
-
His holdings increased from 7,000 to 10,000 shares, raising his stake from 0.05% to 0.08%.
-
Total outstanding shares remain unchanged at 13,320,000.
-
The purchase amount (approx. KRW 53.6 million) is negligible relative to market cap, reflecting a minor insider buy.
KOSPI Filing Information
-
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
-
Company: Samjin Pharmaceutical (005500)
-
Submission: Sangjin Kim
-
Receipt: 05-21-2026